RELiZORB

RELiZORB is an FDA 510(k)-cleared medical device (K191379) manufactured by Alcresta Therapeutics, Inc.. This device is classified under the Gastroenterology, Urology specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on December 3, 2019. Regulation: 8.